Skip to main content
. Author manuscript; available in PMC: 2013 Mar 19.
Published in final edited form as: JAMA. 2011 Nov 9;306(18):1983–1992. doi: 10.1001/jama.2011.1610

Table 2.

Medical Therapy at Last Follow-up

Surgical Group Nonsurgical Group P Valuea
Participants, No. 97 98
Use of anti-thrombotic medication, No. (%) 89/95 (94) 88/94 (94) .99
Systolic Blood Pressure≤ 130 mm Hg, No. (%) 34/76 (45) 29/69 (42) .87
Diastolic Blood Pressure≤ 85 mm Hg, No. (%) 62/76 (82) 48/69 (70) .12
Cigarette smoking (not currently smoking) No. (%) 60/95 (63) 57/92 (62) .79
LDL-cholesterol≤ 100 mg/dL, No. (%) 46/72 (64) 44/62 (71) .46
Triglycerides≤ 150 mg/dL, No. (%) 45/75 (60) 42/64 (66) .60
Hemoglobin A1C≤ 7%, No. (%) 65/74 (88) 53/64 (83) .47
a

P-values from Fisher exact tests. LDL- low density lipoprotein